Inflammation-associated lymphangiogenesis: a double-edged sword? - Wikidata - wikimedia - TriplyDB

Inflammation-associated lymphangiogenesis: a double-edged sword?

Inflammation-associated lymphangiogenesis: a double-edged sword?

http://www.wikidata.org/entity/Q37609665

about

Lymphatic Vessels, Inflammation, and Immunity in Skin Cancer Lymphatics in Neurological Disorders: A Neuro-Lympho-Vascular Component of Multiple Sclerosis and Alzheimer's Disease?Regulatory T cell transfer ameliorates lymphedema and promotes lymphatic vessel function Primary and secondary lymphatic valve development: molecular, functional and mechanical insights.Corneal Lymphatics: Role in Ocular Inflammation as Inducer and Responder of Adaptive Immunity.Bridging the divide between pathogenesis and detection in lymphedema.A zebrafish model of inflammatory lymphangiogenesis Phenotypically heterogeneous podoplanin-expressing cell populations are associated with the lymphatic vessel growth and fibrogenic responses in the acutely and chronically infarcted myocardium.TIE-2-expressing monocytes are lymphangiogenic and associate specifically with lymphatics of human breast cancer VEGFR-3 blocking deteriorates inflammation with impaired lymphatic function and different changes in lymphatic vessels in acute and chronic colitis.Local inhibition of elastase reduces EMILIN1 cleavage reactivating lymphatic vessel function in a mouse lymphoedema model A Critical Role for Monocytes/Macrophages During Intestinal Inflammation-associated Lymphangiogenesis Bimodal Expansion of the Lymphatic Vessels Is Regulated by the Sequential Expression of IL-7 and Lymphotoxin α1β2 in Newly Formed Tertiary Lymphoid Structures.Lymphatic endothelial cells attenuate inflammation via suppression of dendritic cell maturation.The Hepatic Lymphatic Vascular System: Structure, Function, Markers, and Lymphangiogenesis.Bidirectional Crosstalk between Lymphatic Endothelial Cell and T Cell and Its Implications in Tumor Immunity.Inflammatory Manifestations of Lymphedema.Prognostic role of lymphatic vessel density and lymphovascular invasion in chemotherapy-naive and chemotherapy-treated patients with invasive breast cancer.Endoplasmic reticulum stress: key promoter of rosacea pathogenesis.The Gastrointestinal Circulation: Physiology and Pathophysiology.Modulation of VEGF-induced migration and network formation by lymphatic endothelial cells: Roles of platelets and podoplanin.Lymphangiogenesis: fuel, smoke, or extinguisher of inflammation's fire?The lymphatic vasculature: development and role in shaping immunity.microRNAs in the Lymphatic Endothelium: Master Regulators of Lineage Plasticity and Inflammation.Novel role of immature myeloid cells in formation of new lymphatic vessels associated with inflammation and tumors.Tuberculosis-diabetes co-morbidity is characterized by heightened systemic levels of circulating angiogenic factors.Therapeutic lymphangiogenesis ameliorates established acute lung allograft rejection.Lymphatic Vessels Balance Viral Dissemination and Immune Activation following Cutaneous Viral Infection Cardiac Lymphatic Vessels, Transport, and Healing of the Infarcted Heart.The draining lymph node in rheumatoid arthritis: current concepts and research perspectives.Therapeutic lymphangiogenesis after myocardial infarction: vascular endothelial growth factor-C paves the way.The lymphatic vasculature revisited.Mesenchymal Stromal Cells Inhibit Inflammatory Lymphangiogenesis in the Cornea by Suppressing Macrophage in a TSG-6-Dependent Manner.Organ-specific lymphatic vasculature: From development to pathophysiology.Interleukin-17A negatively regulates lymphangiogenesis in T helper 17 cell-mediated inflammation.Lymphangiogenesis guidance by paracrine and pericellular factors.Targeting lymphatic function as a novel therapeutic intervention for rheumatoid arthritis.Potential lymphangiogenesis therapies: Learning from current antiangiogenesis therapies-A review.COMP-angiopoietin-1 ameliorates inflammation-induced lymphangiogenesis in dextran sulfate sodium (DSS)-induced colitis model.Chronic Rejection of Cardiac Allografts Is Associated With Increased Lymphatic Flow and Cellular Trafficking.

P2860

Q26778332-1B599F1D-7F38-4EA6-BD81-3381B4BDD1C2 Q30275974-BC9EFAB5-873B-49AD-8B57-E92BC4B0DC83 Q30819489-49239779-8BD1-4CD0-8317-917E775D0BDF Q34432002-5BA895C4-C253-48AA-AE52-54789CA67438 Q34881185-DDD9E7FA-C6C1-47C2-AAB0-FBC5D5E458AD Q35566114-49C6E4EF-A0CC-4355-8F4A-52704C07164A Q36175340-8C08FC66-D676-444F-93BE-A5669147EE7D Q36319690-60DF2DDC-EADD-471B-BDFF-49F36D0CA7EB Q36710907-E80B2D90-C543-4FA6-996F-DF5A121A6F4C Q36841257-0CC84875-1C44-4762-9BC7-FB12519AF3DD Q36954052-D0FFBB41-6817-454D-9DA8-B14E293C1C5F Q37017572-C865313B-21D6-4E9F-B5EA-8212D276AECE Q37189681-81805A00-7A89-4A82-AA51-C7F7262E612F Q37457544-7C2C2C5C-415B-4B44-B12E-636C1407EDE2 Q37588806-DF6F86B6-E2BF-40D2-BD09-9F0CDA65C6B9 Q37625551-DEF95C2C-58D9-4B8F-8886-F4142C12B269 Q37631642-98DF1A15-2924-4A15-8C0C-DA6E046BBE03 Q37733061-44F5CEB9-F7E3-4FDF-8E6D-E4C18C4650C5 Q38232251-D5397731-0919-4062-A990-A98240CAF95F Q38542463-65D64C8E-16A3-4B67-80F4-FE97626CF5E5 Q38670274-9F3834D1-BA00-49B0-B677-E7F8E5AE680F Q38739268-C21C69DD-8686-4AEF-A82F-598C309F79D7 Q38810930-A82499C1-75AA-4FC5-8EFB-C7F4C1E37456 Q39148619-6C8B4B7B-4B6A-44A5-8646-89F784057DCE Q39241349-FAAD949F-3537-41EC-9C90-D6BD92529357 Q39310832-B88BB9A6-71E7-43AE-8957-AEEF98507BD9 Q40410213-5271C7D8-6260-4208-9232-C378E5BE9C9C Q41664330-FBF9536A-CB7D-4CC1-B42E-E4B55B3BA853 Q42178812-5EB5FAED-06EA-476F-B11B-F83EAB9D3B50 Q42181555-9CF16152-6D77-413D-9D81-A3BE5E7BCA95 Q42331893-514F95A5-992A-439F-AFE0-36F12F2ABD31 Q42427746-5B654BE3-EF6B-46D6-BEE0-7CF0DA3ACD59 Q47209508-7C59D72F-5FAE-459E-8560-52D6F75DFE37 Q47248578-7F095FDA-CF31-4DFC-9F3A-96A3443B3F54 Q47655346-34B5062C-B05E-494A-A2EC-C7178605A388 Q47744569-1AE257CF-7EAA-4CA6-A706-84F80647D2E5 Q48542106-7BBC9413-A5D2-49F5-B713-B0C3798071A5 Q50419857-7DBF4496-E77F-4D39-9BF7-91E20B9450EF Q51730548-8481AA5C-0951-46C1-99F7-37EBF4809FFF Q52683631-B8AA0A47-AE75-4CCD-929A-8F3BEC421885

P2860

Inflammation-associated lymphangiogenesis: a double-edged sword?

http://www.wikidata.org/entity/Q37609665

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 03 March 2014

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Inflammation-associated lymphangiogenesis: a double-edged sword?

@en

Inflammation-associated lymphangiogenesis: a double-edged sword?

@nl

type

label

Inflammation-associated lymphangiogenesis: a double-edged sword?

@en

Inflammation-associated lymphangiogenesis: a double-edged sword?

@nl

prefLabel

Inflammation-associated lymphangiogenesis: a double-edged sword?

@en

Inflammation-associated lymphangiogenesis: a double-edged sword?

@nl

P1433

Q37609665-DD2455AA-1671-4C01-8D61-766D08DDF1F7

P1476

Q37609665-4773DFE7-96D9-4210-A909-581C5C337D12

P2093

Q37609665-715688CA-FB01-4330-B5B1-49FF063D88E8

Q37609665-83EAD975-13E6-44DA-8D01-2F4173689FD0

Q37609665-E6756910-6850-4269-939B-DA87A0D7637D

P2860

Q37609665-04A6514C-7B72-4763-A3B1-563525CF0B75

Q37609665-06123461-F2AA-4934-85A8-49C0FD505BA9

Q37609665-07399580-B43D-4F97-9DBB-FA2A0E108BC8

Q37609665-0B833A64-488A-45B1-99C2-C14E472DDB9E

Q37609665-0F098A12-FAED-47ED-ACE8-AB798952A511

Q37609665-0F8D22C9-9617-44D6-87F8-B8B01217DC0C

Q37609665-1129E51E-9078-4594-A4C3-C0910ACD0232

Q37609665-1883B4DE-9999-4904-886B-F58877FF7650

Q37609665-1A57E072-4630-4F87-ACED-96932EFD82AC

Q37609665-2156B9C2-A165-4E56-B6FC-C77901B56DB9

P304

Q37609665-88E3EC97-9D79-4ED9-A068-EA57F863E28B

P31

Q37609665-2983A492-10EE-402B-8161-D6AE384B7F9D

P356

Q37609665-E8F2DE20-5546-425B-9F26-704CB2F71EED

P407

Q37609665-5E21B1D0-B620-4D8B-8A76-0B9465BB8809

P433

Q37609665-6C652A09-0E63-4C70-AA05-08A99403E5C0

P478

Q37609665-2DD55BCA-47AE-4CB8-A12A-2C6B8418A508

P577

Q37609665-38459760-0FB3-4994-B837-20C2C8335909

P698

Q37609665-52D50CC5-1F32-4B62-BF31-45F2FE6980D2

P921

Q37609665-105DF23D-20C1-42B2-AA4B-1126093F4805

Q37609665-94C4E7A2-1BEC-4E19-9580-482B59267616

P932

Q37609665-1FF4F2DA-BB4A-4871-B1DE-5479ED9C7F2C

P356

P1433

Journal of Clinical Investigation

P1476

Inflammation-associated lymphangiogenesis: a double-edged sword?

@en

P2093

Gou Young Koh

http://www.w3.org/2001/XMLSchema#string

Honsoul Kim

http://www.w3.org/2001/XMLSchema#string

Raghu P Kataru

http://www.w3.org/2001/XMLSchema#string

P2860

Inflammation and insulin resistance

CCR7 and its ligands: balancing immunity and tolerance

Tumor-associated macrophages express lymphatic endothelial growth factors and are related to peritumoral lymphangiogenesis

Functionally specialized junctions between endothelial cells of lymphatic vessels

Lymphangiogenesis is required for pancreatic islet inflammation and diabetes

Resolution of inflammation: the beginning programs the end

Type 2 diabetes as an inflammatory disease

Lymphatic neoangiogenesis in human kidney transplants is associated with immunologically active lymphocytic infiltrates.

Lymphatic endothelial cells - key players in regulation of tolerance and immunity

Podoplanin-expressing cells derived from bone marrow play a crucial role in postnatal lymphatic neovascularization.

P304

936-942

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1172/JCI71607

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

124

http://www.w3.org/2001/XMLSchema#string

P577

2014-03-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24590279

http://www.w3.org/2001/XMLSchema#string

P921

lymphangiogenesis

P932

3938274

http://www.w3.org/2001/XMLSchema#string